Stemone Biologicals Profile
Key Indicators
- Authorised Capital ₹ 1.80 Cr
as on 05-12-2024
- Paid Up Capital ₹ 1.21 Cr
as on 05-12-2024
- Company Age 19 Year, 6 Months
- Last Filing with ROC 31 Mar 2012
- Open Charges ₹ 8.00 M
as on 05-12-2024
- Satisfied Charges ₹ 1.45 Cr
as on 05-12-2024
About Stemone Biologicals
The Corporate was formerly known as Cord Life Biotech Private Limited. The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2012. It's a company limited by shares with an authorized capital of Rs 1.80 Cr and a paid-up capital of Rs 1.21 Cr.
The company currently has active open charges totaling ₹8.00 M. The company has closed loans amounting to ₹1.45 Cr, as per Ministry of Corporate Affairs (MCA) records.
Manish Doshi, Kedarnath Sathe, Chaitanya Purandare, and Two other members serve as directors at the Company.
- CIN/LLPIN
U85199PN2005PTC020895
- Company No.
020895
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Jun 2005
- Date of AGM
25 Sep 2012
- Date of Balance Sheet
31 Mar 2012
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Stemone Biologicals?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manish Doshi  | Director | 26-Jun-2010 | Current |
| Kedarnath Sathe | Director | 21-Jan-2008 | Current |
| Chaitanya Purandare | Director | 17-Jun-2005 | Current |
| Arun Purandare | Director | 01-Oct-2007 | Current |
| Sweta Shah | Director | 26-Jun-2010 | Current |
Financial Performance of Stemone Biologicals.
Enhance accessibility to Stemone Biologicals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Stemone Biologicals?
Unlock access to Stemone Biologicals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Samartha Sahakari Bank Ltd Solapur Creation Date: 05 Nov 2009 | ₹8.00 M | Open |
Hdfc Bank Limited Creation Date: 20 Jun 2012 | ₹1.00 Cr | Satisfied |
Vidya Sahakari Bank Limited Creation Date: 03 Oct 2008 | ₹1.70 M | Satisfied |
How Many Employees Work at Stemone Biologicals?
Unlock and access historical data on people associated with Stemone Biologicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Stemone Biologicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Stemone Biologicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
